These “early-onset” forms compose less than 5% of all AD cases and are associated with mutations in genes involved in the amyloid-processing pathway, such as presenilin 1 (PSEN1) and 2 (PSEN2) and amyloid precursor protein (APP) [5]. Here, PSEN1 is linked to Alzheimer disease.